Table 2.
Models | Men | Women | ||
r | P value | r | P value | |
NAFLD defined by | ||||
USFLI score | 0.404* | <0.001 | 0.395* | <0.001 |
Fibrosis defined by | ||||
NFS score | −0.029 | 0.140 | 0.019 | 0.328 |
FIB-4 | 0.026 | 0.185 | −0.013 | 0.514 |
APRI score | −0.030 | 0.118 | −0.047 | 0.017 |
Partial correlation coefficients are calculated by adjusting for HOMA-IR, CRP and the same variable between VAI and NAFLD indices (WC for USFLI; BMI for NFS).
*P<0.001.
APRI, AST to platelet ratio index; AST, aspartate aminotransferase; BMI, body mass index; CRP, C reactive protein; FIB-4, fibrosis-4 index; HOMA-IR, homeostasis model assessment of insulin resistance; NAFLD, non-alcoholic fatty liver disease; NFS, NAFLD fibrosis score; USFLI, US fatty liver index; VAI, visceral adiposity index; WC, waist circumference.